Cognitive disorders: Mild cognitive impairment and Alzheimer's disease

Charlene H. Snyder; Bryan K. Woodruff; Richard J. Caselli

doi:10.1002/9781119067344.ch18

Cognitive disorders: Mild cognitive impairment and Alzheimer's disease

Charlene H. Snyder, Bryan K. Woodruff, Richard J. Caselli

Neurology

Research output: Chapter in Book/Report/Conference proceeding › Chapter

1 Scopus citations

Abstract

This chapter is an evidence-based review of a clinical topic of importance in dementia care: management of Alzheimer's disease. Four focused, answerable questions are critically appraised: (1) treatment of mild cognitive impairment to delay progression to AD, (2) treatment of mild to moderate dementia due to AD, (3) treatment of moderate to severe dementia due to AD, and (4) treatment of agitation in dementia. This chapter delves into the evidence itself, discusses the findings, provides a short summary of the results with commentary, and emphasizes the clinical bottom line or take-home summary message and implications for practice.

Original language	English (US)
Title of host publication	Evidence-Based Neurology
Subtitle of host publication	Management of Neurological Disorders: Second Edition
Publisher	Wiley-Blackwell
Pages	173-190
Number of pages	18
ISBN (Electronic)	9781119067344
ISBN (Print)	9780470657782
DOIs	https://doi.org/10.1002/9781119067344.ch18
State	Published - Dec 11 2015

Keywords

Alzheimer's disease (AD)
Alzheimer's disease treatment
Dementia
Evidence-based
Mild cognitive impairment
Mild cognitive impairment treatment
Treatment of agitation in Alzheimer's disease

ASJC Scopus subject areas

Medicine(all)

Access to Document

10.1002/9781119067344.ch18

Cite this

@inbook{288ca7f6043b4d75aff44661d97fe4d7,

title = "Cognitive disorders: Mild cognitive impairment and Alzheimer's disease",

abstract = "This chapter is an evidence-based review of a clinical topic of importance in dementia care: management of Alzheimer's disease. Four focused, answerable questions are critically appraised: (1) treatment of mild cognitive impairment to delay progression to AD, (2) treatment of mild to moderate dementia due to AD, (3) treatment of moderate to severe dementia due to AD, and (4) treatment of agitation in dementia. This chapter delves into the evidence itself, discusses the findings, provides a short summary of the results with commentary, and emphasizes the clinical bottom line or take-home summary message and implications for practice.",

keywords = "Alzheimer's disease (AD), Alzheimer's disease treatment, Dementia, Evidence-based, Mild cognitive impairment, Mild cognitive impairment treatment, Treatment of agitation in Alzheimer's disease",

author = "Snyder, {Charlene H.} and Woodruff, {Bryan K.} and Caselli, {Richard J.}",

year = "2015",

month = dec,

day = "11",

doi = "10.1002/9781119067344.ch18",

language = "English (US)",

isbn = "9780470657782",

pages = "173--190",

booktitle = "Evidence-Based Neurology",

publisher = "Wiley-Blackwell",

}

TY - CHAP

T1 - Cognitive disorders

T2 - Mild cognitive impairment and Alzheimer's disease

AU - Snyder, Charlene H.

AU - Woodruff, Bryan K.

AU - Caselli, Richard J.

PY - 2015/12/11

Y1 - 2015/12/11

N2 - This chapter is an evidence-based review of a clinical topic of importance in dementia care: management of Alzheimer's disease. Four focused, answerable questions are critically appraised: (1) treatment of mild cognitive impairment to delay progression to AD, (2) treatment of mild to moderate dementia due to AD, (3) treatment of moderate to severe dementia due to AD, and (4) treatment of agitation in dementia. This chapter delves into the evidence itself, discusses the findings, provides a short summary of the results with commentary, and emphasizes the clinical bottom line or take-home summary message and implications for practice.

AB - This chapter is an evidence-based review of a clinical topic of importance in dementia care: management of Alzheimer's disease. Four focused, answerable questions are critically appraised: (1) treatment of mild cognitive impairment to delay progression to AD, (2) treatment of mild to moderate dementia due to AD, (3) treatment of moderate to severe dementia due to AD, and (4) treatment of agitation in dementia. This chapter delves into the evidence itself, discusses the findings, provides a short summary of the results with commentary, and emphasizes the clinical bottom line or take-home summary message and implications for practice.

KW - Alzheimer's disease (AD)

KW - Alzheimer's disease treatment

KW - Dementia

KW - Evidence-based

KW - Mild cognitive impairment

KW - Mild cognitive impairment treatment

KW - Treatment of agitation in Alzheimer's disease

UR - http://www.scopus.com/inward/record.url?scp=85017991505&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85017991505&partnerID=8YFLogxK

U2 - 10.1002/9781119067344.ch18

DO - 10.1002/9781119067344.ch18

M3 - Chapter

AN - SCOPUS:85017991505

SN - 9780470657782

SP - 173

EP - 190

BT - Evidence-Based Neurology

PB - Wiley-Blackwell

ER -

Cognitive disorders: Mild cognitive impairment and Alzheimer's disease

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this